Medical Devices Startups

Octagos Health offers an AI-powered platform that generates clinical reports, automates workflows, and provides customized EHR integrations and patient data migration for healthcare providers. Its tools are aimed at improving clinical accuracy and supporting clinical decision-making.

1 investor

Octin Health develops the Elika Device, a surgical technology intended to let cardiovascular surgeons perform aortic arch surgery without deep hypothermic circulatory arrest, aiming to reduce the risk of aortic aneurysm and dissection procedures. Founded by a practicing cardiovascular surgeon, the company targets hospitals and cardiac surgery teams; the device is in early development and not yet FDA cleared.

1 investor

Oculaudio develops hearing aids designed for aesthetic appeal and user-friendliness, targeting people with hearing loss who experience fatigue from concentration required in daily listening situations.

1 investor

Ocumetra develops data science and business intelligence tools focused on myopia management and eye health for eye care professionals, including optometrists and ophthalmologists. The company creates clinical analytics platforms to help improve patient outcomes in childhood myopia management.

1 investor

Ocutec is a life sciences company developing advanced materials and technologies for contact lenses and ophthalmic applications. It works in the medical device and biomaterials space.

1 investor

Ocuvera makes an AI-powered, camera-based patient monitoring system that predicts when hospital patients are about to get out of bed or a chair unassisted and sends automated alerts to nurses to help prevent falls. The system is aimed at hospitals and nursing staff, combining a 3D-camera sensor, mobile app, monitoring station, and reporting portal.

1 investor

OD-OS manufactures the Navilas® 577s, a navigated retina laser system for ophthalmologic treatments including photocoagulation, microsecond pulsing therapy, and laser trabeculoplasty. The system serves retinal specialists and clinics performing precision laser treatments for conditions such as diabetic macular edema, central serous chorioretinopathy, and glaucoma.

1 investor

Odne develops OdneClean, an endodontic irrigation protocol and technology for root canal treatment in dentistry. The company serves dental professionals and endodontists seeking improved cleaning and disinfection of root canal systems.

1 investor

OFFOR Health provides mobile healthcare services to underserved populations in the United States, operating SmileMD for in-office anesthesia and sedation during pediatric dental procedures and IH Care+ for integrated health access. The company brings care directly to patients and dental offices to avoid hospital visits.

1 investor

A skincare product company selling capsules designed to work with the Lightinderm device for anti-aging treatments using red light, blue light, and active ingredients. Based in France with physical retail locations across France, Belgium, and online sales.

1 investor

Oh my teeth provides at-home aligner orthodontic treatment through domestically-manufactured clear aligners, combining medical technology with digital support including 3D simulation, at-home delivery, and 24/7 online consultation via LINE. The company serves patients seeking convenient and affordable teeth straightening solutions in Japan.

1 investor

OIS is a conference and community, active since 2009, focused on eye care and ophthalmology innovation, connecting startups, strategics, investors, and clinicians. It provides curated programming, networking, and access to new technologies in the ophthalmology industry.

1 investor

Oivi provides a fully automated retinal screening solution that lets primary care staff perform diabetic eye screening in minutes without specialist training, delivering results within the clinical workflow. It targets primary care clinics in the US to close the diabetic retinopathy screening gap and detect eye diseases such as cataract and glaucoma.

1 investor

Ojer Pharma develops pharmaceutical and cosmetic products for treating skin conditions and infections in human and veterinary markets. The company offers prescription medications, over-the-counter treatments, and dermatological cosmetics addressing conditions ranging from bacterial skin infections to actinic keratosis and herpes simplex.

1 investor

Okami Medical develops the LOBO vascular occlusion system, an occluder built on high-density, small-pore HDBRAID technology for fast arterial occlusion in the peripheral vasculature, along with SENDERO microcatheters and delivery catheters. Its products are intended for physicians treating peripheral vascular conditions.

1 investor

Okeiro is a medical platform using predictive algorithms to monitor transplant and chronic disease patients. It serves healthcare providers with remote monitoring and clinical decision support for organ transplant recipients and patients with renal, cardiac, hepatic, and pulmonary insufficiencies.

1 investor

OU Health is Oklahoma's comprehensive academic health system partnered with the University of Oklahoma, operating hospitals, clinics, and centers of excellence that serve patients across Oklahoma and the region. The organization operates over 11,000 employees including more than 1,300 physicians, managing specialized facilities including a children's hospital, an NCI-designated cancer center, and a Level I trauma center.

1 investor

Olatec develops a pharmaceutical platform targeting acute and chronic inflammatory diseases, with its lead compound dapansutrile (OLT1177), a NLRP3 inhibitor currently in Phase 2 clinical trials in the US and Europe.

1 investor

OLI Technologies develops technology for decentralizing kidney care, working on chemistry, mechanical, and software engineering to support treatment outside centralized clinical settings. The company is developing a medical device, having completed its first animal study.

1 investor

Olympus develops and distributes medical devices and technologies for minimally invasive therapeutic and diagnostic procedures, serving healthcare providers globally.

1 investor

Olympus develops medical technologies and solutions for detecting and treating disease. The company serves healthcare systems, patients, and medical professionals globally.

1 investor

OmniBuds develops ear-worn biosensing earbuds that continuously monitor cardiovascular and physiological signals through AI-powered analysis. The platform serves researchers, clinicians, and health-conscious individuals seeking accessible, unobtrusive insight into their body's cardiovascular responses during daily life.

1 investor

Omnicell develops medication management and automation solutions for healthcare facilities, enabling autonomous pharmacy operations across various care settings.

1 investor

OmniCyte is a biotechnology company developing vaccines and cancer immunotherapies, including a SARS-CoV-2 vaccine program and immune-response engineering work conducted in collaboration with academic medical centers. Its research focuses on recombinant vaccine development and immuno-oncology approaches.

1 investor